| Anne Middleton, LCSW | |
|
333 S 3rd St, Bardstown, KY 40004-1032 | |
| (502) 348-9206 | |
| (502) 348-6485 |
| Full Name | Anne Middleton |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 333 S 3rd St, Bardstown, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154378586 | NPI | - | NPPES |
| 11490553 | Other | CAQH | |
| 341185 | Other | KY | TRICARE |
| 000000314638 | Other | KY | ANTHEM |
| 30605018 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 611 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anne Middleton, LCSW 107 Cranes Roost Ct, Elizabethtown, KY 42701-3650 Ph: (270) 765-2605 | Anne Middleton, LCSW 333 S 3rd St, Bardstown, KY 40004-1032 Ph: (502) 348-9206 |
News Archive
Now patients with mild to moderate plaque psoriasis have a new topical treatment option available by prescription. Zithranol™-RR (anthralin rapid release microcrystalline encapsulated cream, 1.2%), is an innovative topical therapy for plaque psoriasis according to Elorac, Inc., a privately held emerging dermatology company. Zithranol™-RR provides an advanced delivery system for anthralin achieving long remission times with no long-term side effects in a steroid-free, silky cream.
"Mental illness and drug abuse can wreak havoc in global societies and economies, and the U.N. General Assembly should devote a special session to the matter, global health experts said" in a PLoS Medicine article published on Tuesday, Agence France-Presse reports (1/17).
Results from a recent clinical trial indicate that intensive blood pressure lowering reduces chronic kidney disease patients' risks of dying prematurely or developing cardiovascular disease. The findings appear in an upcoming issue of the Journal of the American Society of Nephrology.
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms compared to placebo in adolescents with ADHD. Vyvanse is also indicated for the treatment of ADHD in children ages 6 to 12 years, and adults.
› Verified 6 days ago
Mckenzie Danielle Linton, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 970 Bloomfield Rd, Bardstown, KY 40004 Phone: 502-509-6717 | |
Mr. Leroy None Redeaux Jr., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 700 Portland Ave Ste B, Bardstown, KY 40004 Phone: 270-234-6695 | |
Paulette Braden-korody, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 415 N 3rd St, Bardstown, KY 40004 Phone: 502-349-6090 | |
Rachel M. Blanford, MSW, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 S Salem Dr, Bardstown, KY 40004 Phone: 502-331-5478 Fax: 502-385-0234 | |
Mrs. Rachael Lyons, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 321 W Stephen Foster Ave, Bardstown, KY 40004 Phone: 502-233-2198 | |
Mr. Mark Alan Cain, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 105 S 5th St, Bardstown, KY 40004 Phone: 502-348-5454 Fax: 502-349-6190 |